Drug Type CAR-T |
Synonyms GPA TriMAR T cell therapy, GPA-TriMAR-T, TCR-mimic-CAR-T + [3] |
Target |
Action inhibitors |
Mechanism gp100 inhibitors(Melanocyte protein PMEL inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Phase 1 | China | 27 Sep 2018 | |
Melanoma | Phase 1 | China | 27 Sep 2018 |